CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mym Nutraceuticals Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mym Nutraceuticals Inc.
Suite 1500
409 West Pender Street
Phone: (604) 559-7513p:604 559-7513 Vancouver, BC  V6C 1T2  Canada
This company was Merged or Acquired on 7/9/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Mym Nutraceuticals Inc, formerly My Marijuana Canada Inc, is a Canada-based company, which is focused on producing cannabis. The Company is engaged in building three scale production facilities in both Canada and Australia. The Company has the following projects: The Weedon Project, which includes a cannabis museum and a cannabis university for industry training and located in Quebec, Canada; The Laval Project is based on the manufacturing Tetrahydrocannabinol and Cannabidiol (CBD) products across Canada and the United States; The Northern Rivers Project is engaged in the production of cannabis in New South Wales, Australia, as well as MJT Manufacturing Project, its production facility located in Toronto, is focused on the production of CBD extracts and isolates. The MJT production facility is focused on product development for the Company’s owned brands. Its portfolio brands include such CBD brands as HempMed, Joshua Tree and Dr.Furbaby. Its products are being sold in Canada.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/28/20215/31/2020Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board HowardSteinberg 4/1/2020 10/24/2018
President, Director RobinLinden 7/31/2020 11/29/2017
Chief Executive Officer, Director MichaelWiener 7/31/2020 7/31/2020
5 additional Officers and Directors records available in full report.

Business Names
Business Name
0MY
1114865 B.C. Ltd
9377-4396 Quebec Inc.
12 additional Business Names available in full report.

General Information
Outstanding Shares: 369,050,427 (As of 6/3/2021)
Stock Exchange: CNQ


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 13, 2024